lncRNA-ATB介导的上皮间质转化在胃癌进展中的机制研究

doi:10.11904/j.issn.1002-3070.2022.03.003

实用肿瘤学杂志 ›› 2022, Vol. 36 ›› Issue (3): 208-213.doi: 10.11904/j.issn.1002-3070.2022.03.003

lncRNA-ATB介导的上皮间质转化在胃癌进展中的机制研究

智亮辉, 刘伟, 李伟, 甄四虎, 焦喜林

中国人民解放军联勤保障部队第九八〇医院普外一科(石家庄 050082)

收稿日期:2021-12-23 修回日期:2022-03-23 出版日期:2022-06-28 发布日期:2022-06-28
通讯作者: 智亮辉,E-mail:dikangaizi2008@163.com
作者简介:智亮辉,男,(1981-),硕士,主治医师,从事消化道肿瘤微创治疗的研究。
基金资助:
河北省卫生健康委员会课题(编号:20191215)

Mechanism of lncRNA-ATB mediated epithelial mesenchymal transition in the progression of gastric cancer

ZHI Lianghui, LIU Wei, LI Wei, ZHEN Sihu, JIAO Xilin

Department of General Surgery,The 980th Hospital of PLA Joint Logistics Support Forces,Shijiazhuang 050082,China

Received:2021-12-23 Revised:2022-03-23 Online:2022-06-28 Published:2022-06-28

摘要/Abstract

摘要： 目的探讨lncRNA-ATB介导的上皮间质转化在胃癌进展中的可能机制。方法采用生物信息学分析预测lncRNA-ATB的下游结合分子并采用荧光素酶报告基因验证。收集联勤保障部队第九八〇医院2017年1月—2019年12月胃癌及癌旁组织标本56例,采用qRT-PCR分析lncRNA-ATB及下游结合分子在胃癌及癌旁组织中的表达水平及二者之间的相关性,并分析二者与胃癌临床病理特征的相关性;在敲降lncRNA-ATB前后的胃癌BGC-823细胞系中,采用qRT-PCR及Western blot实验验证miR-200a、β-catenin、vimentin、E-cadherin表达水平的变化。结果生物信息学分析发现lncRNA-ATB与miR-200a有直接结合位点,miR-200a与β-catenin能直接结合并采用荧光素酶报告基因验证。lncRNA-ATB在胃癌组织中较癌旁组织中明显高表达(P＜0.001),miR-200a在胃癌组织中较癌旁组织中明显低表达,差异有统计学意义(P＜0.001)。在胃癌组织中lncRNA-ATB与miR-200a表达水平呈负相关(r=-0.317,P=0.017)。lncRNA-ATB在Ⅲ、Ⅳ期胃癌较Ⅰ、Ⅱ期表达水平明显升高,淋巴结转移阳性组、脉管内癌栓阳性及肿瘤低分化组lncRNA-ATB表达水平更高,差异有统计学意义(P＜0.001)。miR-200a在Ⅲ、Ⅳ期胃癌患者较Ⅰ、Ⅱ期患者表达水平明显降低,淋巴结转移阳性组、脉管内癌栓阳性及肿瘤低分化组miR-200a表达水平明显降低,差异有统计学意义(P＜0.05)。在胃癌BGC-823细胞系中敲降lncRNA-ATB后β-catenin和vimentin表达降低、E-cadherin表达升高,差异有统计学意义(P＜0.05)。结论 lncRNA-ATB通过与miR-200a结合,影响β-catenin的表达促进上皮间质转化进程从而影响胃癌进展。

关键词: 胃癌, lncRNA-ATB, 上皮间质转化

Abstract: Objective The objective of this study was to investigate the possible mechanism of lncRNA-ATB mediated epithelial-mesenchymal transition(EMT)in the progression of gastric cancer. Methods The downstream binding molecules of lncRNA-ATB were predicted by bioinformatics analysis and verified by luciferase reporter gene.A total of 56 gastric cancer and adjacent tissue specimens from the 980th Hospital of the Joint Logistics Support Force were collected from January 2017 to December 2019.The levels of lncRNA-ATB and the downstream binding molecules in gastric cancer and adjacent tissues as well as their relationship were analyzed by qRT-PCR.Its correlation with clinicopathological features of gastric cancer was also analyzed.The expression of miR-200a,β-catenin,vimentin and E-cadherin was confirmed by qRT-PCR and Western blot in gastric cancer BGC-823 cells before and after knockdown of lncRNA-ATB. Results Bioinformatics analysis showed that lncRNA-ATB had a direct binding site to miR-200a,and miR-200a could directly bind to β-catenin,which was verified by luciferase reporter gene.The expression of lncRNA-ATB in gastric cancer tissues was significantly higher than that in adjacent tissues(P＜0.001),and the expression of miR-200a in gastric cancer was significantly lower than that in adjacent tissues,the difference was statistically significant(P＜0.001).There was a negative correlation between the levels of lncRNA-ATB and miR-200a in gastric cancer tissues(r=-0.317,P=0.017).The expression of lncRNA-ATB in the stage III and IV gastric cancer was significantly higher than that in the stage I and II gastric cancer,and the expression of lncRNA-ATB in patients with the lymph node metastasis positive group,vascular tumor thrombus positive group and tumor poorly differentiated group was significantly higher than that in the negative group,and the difference was statistically significant(P＜0.001).The expression of miR-200a in the stage III and IV gastric cancer patients was significantly lower than that in the stage I and II patients,and the expression of miR-200a in patients with the lymph node metastasis positive group,vascular tumor thrombus positive group and tumor poorly differentiated group was significantly lower than that in the negative group,and the difference was statistically significant(P＜0.05).After knockdown of lncRNA-ATB in BGC-823 cells,the expression of β-catenin and vimentin was decreased and the expression of E-cadherin was increased,and the differences were statistically significant(P＜0.05). Conclusion lncRNA-ATB can affect the progression of gastric cancer by binding to miR-200a,affecting the expression of β-catenin and promoting the process of EMT.

Key words: Gastric cancer, lncRNA-ATB, Epithelial-mesenchymal transition

中图分类号:

R735.2

智亮辉, 刘伟, 李伟, 甄四虎, 焦喜林. lncRNA-ATB介导的上皮间质转化在胃癌进展中的机制研究[J]. 实用肿瘤学杂志, 2022, 36(3): 208-213.

ZHI Lianghui, LIU Wei, LI Wei, ZHEN Sihu, JIAO Xilin. Mechanism of lncRNA-ATB mediated epithelial mesenchymal transition in the progression of gastric cancer[J]. Journal of Practical Oncology, 2022, 36(3): 208-213.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2022.03.003

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2022/V36/I3/208

参考文献

1 Zheng R,Zhang S,Zeng H,et al.Cancer incidence and mortality in China,2016[J].J Natl Cancer Cent,2022,2(1):1-9.
2 Tian S,Peng P,Li J,et al.SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway[J].Aging(Albany NY),2020,12(4):3574-3593.
3 Seeneevassen L,Bessède E,Mégraud F,et al.Gastric cancer:advances in carcinogenesis research and new therapeutic strategies[J].Int J Mol Sci,2021,22(7):3418.
4 Smyth EC,Nilsson M,Grabsch HI,et al.Gastric cancer[J].Lancet,2020,396(10251):635-648.
5 Rinn JL,Chang HY.Long Non-coding RNAs:molecular modalities to organismal functions[J].Annu Rev Biochem,2020,89(10):283-308.
6 Lorenzi L,Avila Cobos F,Decock A,et al.Long non-coding RNA expression profiling in cancer:challenges and opportunities[J].Genes Chromosomes Cancer,2019,58(4):191-199.
7 Zhang L,Li C,Su X.Emerging impact of the long non-coding RNA MIR22HG on proliferation and apoptosis in multiple human cancers[J].J Exp Clin Cancer Res,2020,39(1):271.
8 Wang J,Lv N,Lu X,et al.Diagnostic and therapeutic role of microRNAs in oral cancer(Review)[J].Oncol Rep,2021,45(1):58-64.
9 Li Z,Wang Y,Liu S,et al.MiR-200a-3p promotes gastric cancer progression by targeting DLC-1[J].J Mol Histol,2022,53(1):39-49.
10 Zhang J,Guo S,Piao HY,et al.ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1[J].J Physiol Biochem,2019,75(3):379-389.
11 Chen HT,Liu H,Mao MJ,et al.Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy[J].Mol Cancer,2019,18(1):101.
12 Yue B,Song C,Yang L,et al.METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer[J].Mol Cancer,2019,18(1):142.
13 Zhu GM,Chen SQ,Jiang QG,et al.MiR-216b inhibits gastric cancer proliferation and migration by targeting PARK7[J].Indian J Pathol Microbiol,2021,64(1):52-57.
14 Yao L,Shi W,Gu J.Micro-RNA 205-5p is involved in the progression of gastric cancer and targets phosphatase and tensin homolog(PTEN)in SGC-7901 human gastric cancer cells[J].Med Sci Monit,2019,25(8):6367-6377.
15 Huang GL,Sun J,Lu Y,et al.MiR-200 family and cancer:From a meta-analysis view[J].Mol Aspects Med,2019,70(12):57-71.
16 Fontana A,Barbano R,Dama E,et al.Combined analysis of miR-200 family and its significance for breast cancer[J].Sci Rep,2021,11(1):2980.
17 Li Y,Wang J,Chen W,et al.Overexpression of STAT4 under hypoxia promotes EMT through miR-200a/STAT4 signal pathway[J].Life Sci,2021,273(3):119263.
18 Tan S,Kang Y,Li H,et al.circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis[J].Cell Death Dis,2021,12(2):168.
19 Yuan D,Zhang X,Zhao Y,et al.Role of lncRNA-ATB in ovarian cancer and its mechanisms of action[J].Exp Ther Med,2020,19(2):965-971.
20 Gao Z,Zhou H,Wang Y,et al.Regulatory effects of lncRNA ATB targeting miR-200c on proliferation and apoptosis of colorectal cancer cells[J].J Cell Biochem,2020,121(1):332-343.
21 Wang CZ,Yan GX,Dong DS,et al.LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma[J].World J Gastroenterol,2019,25(35):5310-5322.

[1]	王洪英, 李岩, 韩鑫浩, 魏孝礼, 贾慧珣, 袁文娟, 张秋菊. 基于免疫相关lncRNAs的胃癌早期诊断和预后风险模型的构建和验证[J]. 实用肿瘤学杂志, 2022, 36(2): 119-126.
[2]	赵宝山, 梁冠盈, 许圣洁, 乔慧, 陈洪霞, 马莹, 鞠学萍, 王麟. PELP1表达与胃癌演进及预后相关性分析[J]. 实用肿瘤学杂志, 2022, 36(1): 31-36.
[3]	邬丽婷, 李大兵, 邓小霞, 李柏松. 2013—2020年重庆市北碚区胃癌疾病负担变化趋势及预测[J]. 实用肿瘤学杂志, 2021, 35(6): 495-499.
[4]	陈奕心, 孙轶华, 程洋洋, 何凯桐, 郭婷. 术前炎症相关指标与可切除胃癌患者预后的相关性[J]. 实用肿瘤学杂志, 2021, 35(6): 517-522.
[5]	于园园, 孟千皓, 王广雨. 胃癌免疫治疗困境与未来方向[J]. 实用肿瘤学杂志, 2021, 35(6): 552-556.
[6]	穆慧娟, 李海娜, 吕艺, 孙丽华, 王丽娟, 礼彦侠, 于飞, 潘国伟, 刘莉. 辽宁省三城市居民胃癌10年生存率及其影响因素分析[J]. 实用肿瘤学杂志, 2021, 35(4): 339-343.
[7]	杜昕,曲泽,赵选忠,侯明星,王峰. miRNA-126和K-Ras及MMP-7在胃癌中的表达及其相关性分析[J]. 实用肿瘤学杂志, 2021, 35(1): 23-27.
[8]	尹松祥. Copine-8在胃癌组织中的表达与临床病理特征及预后的相关性[J]. 实用肿瘤学杂志, 2020, 34(5): 430-435.
[9]	李健, 马麒, 任瑾, 呼圣娟. 胃癌影响因素研究进展[J]. 实用肿瘤学杂志, 2020, 34(5): 466-470.
[10]	石琳娜, 隋红. 早期胃癌淋巴结转移评估方法的研究现状[J]. 实用肿瘤学杂志, 2020, 34(3): 286-290.
[11]	周家琛, 郑荣寿, 庄贵华, 张思维, 曾红梅, 陈茹, 王少明, 孙可欣, 邹小农, 魏文强, 赫捷. 2000—2015年中国肿瘤登记地区胃癌发病趋势及年龄变化[J]. 实用肿瘤学杂志, 2020, 34(1): 1-5.
[12]	戴丹, 贾尚春, 陈叶纪, 贺琴, 查震球, 刘志荣. 安徽省肿瘤登记地区2015年胃癌发病与死亡[J]. 实用肿瘤学杂志, 2020, 34(1): 6-10.
[13]	王鸣, 孙梯业. PFKFB4对胃癌细胞侵袭和迁移能力的影响及其作用[J]. 实用肿瘤学杂志, 2020, 34(1): 37-42.
[14]	来森艳, 胡发涌, 吴维, 李国东, 李小兰, 曹小年. DAB2IP稳定细胞系的构建及其对结直肠癌HT29细胞侵袭迁移能力的影响[J]. 实用肿瘤学杂志, 2019, 33(5): 385-389.
[15]	徐亭, 严斐斐, 张纯慧, 张艳桥. 胃癌骨转移患者临床病理与预后分析[J]. 实用肿瘤学杂志, 2019, 33(5): 436-441.

lncRNA-ATB介导的上皮间质转化在胃癌进展中的机制研究

Mechanism of lncRNA-ATB mediated epithelial mesenchymal transition in the progression of gastric cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价